CD274 and melanoma: BCG has upregulated PD-L1 expression in PBMCs of melanoma patients, which raises the question of what kind of therapeutic effect PD-L1 expression in PBMCs has versus bladder tumors and versus brain cells in preventing AD, which must be investigated in the future.